How to use this tool: Enter the current INR, the weekly dose and the target range. The tool calculates the total weekly dose adjustment, provides day-by-day initiation nomograms, and converts between vitamin K antagonists.
1. Clinical Objective & Agent
2. Clinical Parameters
Practice Pearl: Always calculate based on the Total Weekly Dose (TWD). Do not use daily averages. E.g., 3mg Mon/Wed/Fri + 2mg other days = TWD of 17mg.
Clinical Action Plan
Academic Pearls & Pathophysiology
1. Pathophysiology: The Procoagulant Window
VKAs (Warfarin, Acenocoumarol) inhibit Vitamin K Epoxide Reductase, preventing the activation of clotting factors II, VII, IX, and X. However, they also rapidly deplete Protein C and Protein S (endogenous natural anticoagulants) which have much shorter half-lives than Factor II. Consequently, the patient enters a transient hypercoagulable state during the first 3-5 days of therapy. This is why bridging with LMWH or unfractionated heparin is physiologically mandatory until the INR reflects true therapeutic Factor II depletion.
2. Illness Scripts: Warfarin vs. Acenocoumarol
Pharmacokinetic Feature
Warfarin
Acenocoumarol (Acitrom)
Half-Life (T½)
Long (36 - 42 hours)
Short (8 - 11 hours)
Time to Steady State
5 to 7 days
2 to 3 days
Clinical Implication
More stable INRs; missing a single dose causes minor fluctuations.
Faster onset/offset. Missing a single dose causes a rapid drop in INR, increasing immediate stroke/clot risk.
Equivalent Dose Ratio
5 mg
2 mg (Acitrom is ~2.5x more potent per mg)
3. Indian Clinical Context: Substitution Caution
[CLINICAL CAUTION] Generic Switching: In Indian OPDs and government hospitals, patients frequently substitute brands based on pharmacy availability (e.g., switching from Warf to Uniwarf, or worse, accidentally switching between Warfarin and Acitrom due to generic naming confusion). Different brands have varying bioavailability. Always mandate an INR check 5 to 7 days after any brand or formulation change.
4. Mnemonic: Target INR Guidelines (The "2.5 Default")
The target INR for almost all standard indications is 2.5 (Range 2.0 - 3.0), including DVT/PE, AFib, and Bioprosthetic valves. The major exception requiring a target of 3.0 (Range 2.5 - 3.5) is the Mechanical Mitral Valve, due to the high-flow, high-thrombogenicity environment of the mitral position.
5. Important Drug Interactions
Increase INR (Bleeding Risk)
Decrease INR (Clotting Risk)
Amiodarone (Reduces VKA dose requirement by ~30-50%)
Rifampicin (Rifampin)
Macrolides, Fluoroquinolones
Carbamazepine, Phenytoin
Azole antifungals, Metronidazole
Phenobarbital
NSAIDs (Increase bleeding risk independent of INR)
Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest. 2021;160(6):e545-e608. [Second update to the 9th edition. DOACs are now recommended over a VKA for treatment-phase anticoagulation in DVT and PE; VKA is retained for patients who cannot receive a DOAC, and for valvular AF and mechanical valves, which is where this titration engine applies.]
Douketis JD, Spyropoulos AC, Murad MH, et al. Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline. Chest. 2022;162(5):e207-e243. [Interrupt VKA at least 5 days before surgery, restart within 24 hours after.]
Holbrook A, et al. Evidence-Based Management of Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012. [Superseded; source of the INR targets and titration nomogram used here.]
Tait RC, Sellar L. A novel rapid-induction regimen for warfarin. Br J Haematol. 1998. (Basis for empirical initiation nomograms).
Indian College of Cardiology / Association of Physicians of India (API). National Consensus on Management of Venous Thromboembolism. J Assoc Physicians India. 2018.
How to Cite This Tool
AMA Style:
Umakanth S. Warfarin & Acitrom (VKA) Titration Pathway. MEDiscuss. Published 2026. Accessed .
Vancouver Style:
Umakanth S. Warfarin & Acitrom (VKA) Titration Pathway [Internet]. MEDiscuss.org; 2026 [cited ]. Available from:
Save this calculation
Whatever you type here stays on this device and is not sent anywhere. The server
receives only a scrambled code made from it, so nobody with access to the server can
tell which patient a saved calculation belongs to. Enter the same nickname the next
time to see that patient's earlier values.
What is stored
